These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11215195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
    Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H, Dimopoulos C.
    J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Aug; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 6. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors].
    Gregersen B, Mommsen S, Svanholm H.
    Ugeskr Laeger; 1999 Apr 05; 161(14):2071-3. PubMed ID: 10354792
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the bladder tumor marker "Tu-MARK-BTA"].
    Yogi S, Ikeuchi T, Yoshikawa H, Hamashima T, Sasaki H, Morikawa F, Onodera Y, Matsumoto K, Kai Y.
    Hinyokika Kiyo; 1991 Apr 05; 37(4):335-9. PubMed ID: 1891992
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer].
    Kurokawa S, Morita T, Muraishi O, Tokue A.
    Hinyokika Kiyo; 2001 Apr 05; 47(4):247-50. PubMed ID: 11411098
    [Abstract] [Full Text] [Related]

  • 11. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.
    Babjuk M, Soukup V, Pesl M, Kostírová M, Drncová E, Smolová H, Szakacsová M, Getzenberg R, Pavlík I, Dvorácek J.
    Urology; 2008 Apr 05; 71(4):718-22. PubMed ID: 18387400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A side by side comparison of cytology and biomarkers for bladder cancer detection.
    Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V.
    J Urol; 2004 Sep 05; 172(3):1123-6. PubMed ID: 15311054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug 05; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 17. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
    Sánchez-Carbayo M, Urrutia M, Silva JM, Romaní R, De Buitrago JM, Navajo JA.
    J Urol; 2001 May 05; 165(5):1462-7. PubMed ID: 11342897
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
    Leyh H, Hall R, Mazeman E, Blumenstein BA.
    Urology; 1997 Jul 05; 50(1):49-53. PubMed ID: 9218018
    [Abstract] [Full Text] [Related]

  • 19. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
    Escaf Barmadah S, Martín Benito JL, Fernández Gómez JM, San Martín Blanco A, Pérez Gracia FJ, Rodríguez Martínez JJ.
    Arch Esp Urol; 1998 Mar 05; 51(2):129-36. PubMed ID: 9586309
    [Abstract] [Full Text] [Related]

  • 20. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
    Boman H, Hedelin H, Holmäng S.
    J Urol; 2002 Jan 05; 167(1):80-3. PubMed ID: 11743280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.